Topics

Companies Related to "Neuropsychological tests Alzheimer Disease" [Most Relevant Company Matches] RSS

23:00 EDT 5th April 2020 | BioPortfolio

Here are the most relevant search results for "Neuropsychological tests Alzheimer Disease" found in our extensive corporate database of over 50,000 company records.

Showing "Neuropsychological tests Alzheimer Disease" Companies 1–25 of 3,300+

Relevant

Cambridge Cognition Ltd

Cambridge Cognition Ltd specialises in computerised cognitive testing. Based in Cambridge, England, the company supplies products and services based on CANTAB®, the Cambridge Neuropsychological Test Automated Battery. The cognitive tests in CANTAB are used for neuropsychological assessment in academic research, pharmaceutical clinical trials and healthcare around the world.


EXPERT BIOMED, INC

Expert BioMed offers a service to pharmaceutical companies providing screening of potential drugs on Alzheimer's disease cell and animal models designed and maintained in the company and data interpretation service in addition to the Expert BioMed systems and platform for new drug development. Expert BioMed offers new monoclonal and polyclonal antibodies, recombinant proteins and peptides as bioma...

Alzheimer's Research Foundation

The Fisher Center for Alzheimer's Research Foundation is a leading source of funding for Alzheimer's research. It serves Alzheimer's patients and their families to understand the causes of Alzheimer's, to discover a cure, and to improve the lives of people with the disease. Nobel laureate Dr. Paul Greengard directs the Foundation's team of internationally renowned scientists, who have been at th...


Neuropsychology Center, P.C.

The Neuropsychology Center is a professional corporation designed to provide clinical neuropsychological services, professional consultation, education and training, and to conduct neuropsychological research. The specific scientific and methodological focus of The Neuropsychology Center is the Halstead-Reitan Neuropsychological Batteries and procedures. The founders of The Neuropsychology Center ...

Alzheimer's Research and Prevention Foundation

The Alzheimer's Research and Prevention Foundation (ARPF) is a non-profit organization dedicated to reducing the incidence of Alzheimer's disease by conducting clinical research and providing educational outreach about the lifestyle changes that can help prevent Alzheimer's disease. For more information, please visit the Alzheimer's Research and Prevention Foundation at www.alzheimersprevention.o...

Alzheimer’s Association, New York City Chapter

Alzheimer’s disease is one of the nation’s largest public health crises. It is the fifth leading cause of death in California and the only leading cause of death that cannot be prevented, cured or even slowed. 630,000 people in California are currently living with Alzheimer’s disease, and more than 1.6 million Californians provide unpaid care for ...

Alzheimer's Foundation International

The Alzheimer's Foundation International (AFI) is working toward collaboratively setting a paradigm of quality care for individuals with the disease and their families by raising awareness of Alzheimer's disease and related dementias, providing education, and establishing programs and services that can be replicated in countries around the globe. Currently, AFI's member organizations are the Alzhe...

The Alzheimer's Association

The Alzheimer's Association is the leading voluntary health organization in Alzheimer care, support and research. Our mission is to eliminate Alzheimer's disease through the advancement of research; to provide and enhance care and support for all affected; and to reduce the risk of dementia through the promotion of brain health. Our vision is a world without Alzheimer's. For more informatio...

Panacea Pharmaceuticals

Panacea Pharmaceuticals, Inc. focuses on developing and utilizing protein-based technologies to detect and identify changes associated with and involved in diseases of the central nervous system such as Alzheimer's disease, brain tumors, transmissible spongiform encephalopathies, and Lewy Body diseases such as Parkinson's disease. Changes in disease-relevant proteins by altered expression, post-tr...

Arizona Alzheimer's Consortium

The Arizona Alzheimer's Consortium is a laboratory without walls designed to leverage the strengths of its seven member institutions to promote the scientific understanding of Alzheimer's disease. The Consortium is attacking Alzheimer's disease by combining breakthroughs in genomic medicine and cutting-edge research with data from sophisticated brain imaging programs and advanced clinical trials t...

The Alzheimer’s Association

The Alzheimer’s Association is the world’s leading voluntary health organization in Alzheimer care, support and research. Its mission is to eliminate Alzheimer’s disease through the advancement of research; to provide and enhance care and support for all affected; and to reduce the risk of dementia through the promotion of brain health. Learn more ...

Avid Radiopharmaceuticals

Founded in 2004, Avid Radiopharmaceuticals, Inc. is a product-focused molecular imaging company that is a pioneer in developing radiopharmaceuticals for imaging Alzheimer's disease pathology. Two of Avid's radiopharmaceuticals are already in clinical trials, and Avid intends to make these products available to pharmaceutical companies that are seeking to develop new drugs for treatment of Alzheime...

Applied NeuroSolutions, Inc.

Applied NeuroSolutions, Inc. (OTC BB:APSN - News) is developing diagnostics and therapeutics to detect and treat Alzheimer's disease (AD) building on discoveries originating from the Albert Einstein College of Medicine. Applied NeuroSolutions is in a collaboration with Eli Lilly and Company to develop novel therapeutic compounds to treat the progres...

Ebixa

Ebixa is an effective, safe and well tolerated therapy, that helps overcome the everyday challenges in Alzheimer’s disease, easing the lives of both patients and their carers. Ebixa is indicated for the treatment of moderate to severe Alzheimer’s disease. Ebixa is a specific, uncompetitive NMDA-receptor antagonist, with a novel mechanism of action that targets the glutamatergic signalling in ...

TM Bioscience Corporation

Tm Bioscience Corporation is a DNA-based Diagnostics company developing a suite of genetic tests.Tm Bioscience’s product pipeline includes tests for genetic mutations related to human disease, pharmacogenetics, and infectious disease.Tm Bioscience has advanced proprietary technologies, including the Universal Array that markedly improves the speed, accuracy, flexibility, and cost of DNA-based ge...

Janssen Alzheimer Immunotherapy

Alzheimer's disease (AD), the most common form of dementia, is a fatal, degenerative brain disease that gradually destroys a person's memory and ability to learn, reason, make judgments, communicate and carry out daily activities, such as bathing and eating. As AD progresses, individuals may also experience changes in personality and behavior, such as anxiety, suspiciousness or agitation, delusion...

Alzheimer's Drug Discovery Foundation

The ADDF is the only public charity whose sole mission is to accelerate the discovery and development of drugs to prevent, treat and cure Alzheimer's disease, related dementias and cognitive aging. Since 1998, the ADDF has granted more than $40 million to fund over 295 Alzheimer's drug discovery programs in academic centers and biotechnology companies in 15 countries.

Alzheimer's Drug Discovery Foundation (ADDF)

Alzheimer's Drug Discovery Foundation (http://www.alzdiscovery.org/) is the only public charity whose sole mission is to fund drug discovery and development to prevent, treat, and cure Alzheimer's disease and cognitive aging. An affiliated public charity of the Institute for the Study of Aging (ISOA), a private foundation established by the Estee Lauder family in 1998, ADDF was established in 2004...

Beta Amyloid Org

Beta Amyloid.org keeps up details of Alzheimer Research Labs, Alzheimer Research conferences around the world. Amyloid peptides being one of the major culprit of the Alzheimer Disease so our goal is to provide anything and everything to the researchers at one website. Beta Amyloid.org access is totally free; however, we don’t endorse any scientific information. Our team of scientists, editors an...

Axonyx

Axonyx is a biopharmaceutical company focused on the acquisition and development of proprietary products and technologies for the treatment and diagnosis of Alzheimer's Disease and other memory-related cognitive disorders including prion diseases such as Mad Cow Disease. After completion of a Phase II Proof of Concept clinical study in October of 2001 for Phenserine, Axonyx's lead product for Alzh...

Alzheimer’s Greater Los Angeles

Alzheimer’s Greater Los Angeles (formerly known as Alzheimer’s Association, California Southland Chapter) provides programs and services free of charge to individuals with Alzheimer’s and related dementias, their families, caregivers and the community. Low cost training and education are also offered for professionals. Alzheimer’s Great...

EXPERT BIOMED

Expert BioMed, Inc. is a privately-held biotechnology R&D company. The company focus is the development of prevention, diagnostic and therapy strategies to combat the Alzheimer's disease. In the Expert BioMed, Alzheimer cell and animal models and a set of monoclonal and polyclonal antibodies directed to new Alzheimer marker have been developed. The new diagnostic test for early cancer detection is...

Alzheon, Inc.

Alzheon, Inc., is a clinical-stage biotechnology company focused on brain health, memory and aging, developing innovative treatments for Alzheimer’s disease and other neurodegenerative disorders. Alzheon pursues drug development programs that have previously been tested in extensive efficacy studies in Alzheimer’s disease patients and where new i...

Alzheimer's Disease International

SOURCE Alzheimer's Disease International

AFFiRiS AG

On the basis of the company's own patents, AFFiRiS develops tailor-made peptide vaccines against Alzheimer's disease, atherosclerosis, Parkinson's disease hypertension and four other conditions with an urgent medical requirement and attractive market volumes. Alzheimer's is currently the most advanced project, with two potential products having just completed the phase I clinical studies. In O...


More From BioPortfolio on "Neuropsychological tests Alzheimer Disease"

Quick Search

Corporate Database Quicklinks